Corcept Therapeutics Inc’s recently made public that its insider Lyon Joseph Douglas unloaded Company’s shares for reported $0.14 million on Apr 04 ’24. In the deal valued at $26.00 per share,5,443 shares were sold. As a result of this transaction, Lyon Joseph Douglas now holds 7,314 shares worth roughly $0.18 million.
Then, Swisher Daniel N JR sold 2,200 shares, generating $55,660 in total proceeds. Upon selling the shares at $25.30, the Director now owns 0 shares.
Before that, Lyon Joseph Douglas sold 500 shares. Corcept Therapeutics Inc shares valued at $13,004 were divested by the insider at a price of $26.01 per share. As a result of the transaction, Lyon Joseph Douglas now holds 7,314 shares, worth roughly $0.18 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -3.85% to $24.23. Over the last five days, the stock has lost -5.87%. Corcept Therapeutics Inc shares have fallen nearly -25.40% since the year began. Nevertheless, the stocks have risen 11.04% over the past one year. While a 52-week high of $34.28 was reached on 01/08/24, a 52-week low of $20.87 was recorded on 02/02/24. SMA at 50 days reached $23.56, while 200 days put it at $26.49. A total of 0.95 million shares were traded, compared to the trading of 0.57 million shares in the previous session.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 23.66, which if violated will result in even more drops to 23.09. On the upside, there is a resistance level at 25.15. A further resistance level may holdings at 26.07. The Relative Strength Index (RSI) on the 14-day chart is 47.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.05%. Stochastics %K at 55.77% indicates the stock is a holding.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on Mar 15, 2024, growing by 0.58 million shares to a total of 20.22 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 19.64 million shares. There was a rise of 2.87%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 31.38% of the overall stock float, the days-to-cover ratio (short ratio) rose to 18.88.
